Shimadzu announces the release of Peakintelligence Ver. 2 (hereinafter Ver. 2) software for triple quadrupole liquid chromatograph mass spectrometers (LC-MS/MS). Equipped with algorithms developed using artificial intelligence (AI), this software automatically detects peaks*1 appearing in chromatograms. By reliably detecting peaks without adjusting parameters, this product substantially reduces the need to visually confirm and correct data. In […]

The initial focus of the collaboration will be on applications for fibrotic diseases and implementing in-house proteomics capabilities Biberach (Baden-Württemberg – Germany) and Schlieren (Zürich – Switzerland): Biognosys announced today that it started working together with Boehringer Ingelheim. Here, Biognosys and Boehringer Ingelheim will team up to expand next-generation proteomics applications in drug discovery programs […]

— Funding to accelerate development and commercial launch of Proteograph™ suite of reagents, instrument and software products to deliver on untapped promise of proteomics — Redwood City, CA — Seer, Inc., a life sciences company focused on empowering exceptional scientific outcomes through the power of rapid, deep, unbiased proteomics information, today announced that it has raised […]

Published results reveal differentiated ability of proprietary, engineered nanoparticle technology to enable large-scale proteomics studies to: Provide new insights into dynamic nature of the proteome Lead to discovery of potentially novel biomarkers Complement large-scale genomics datasets to advance overall understanding of human biology Redwood City, CA — Seer, Inc. announced the publication in Nature Communications today of a study […]

FRAMINGHAM, Mass.– SCIEX, a global leader in life science analytical technologies, introduces the fully integrated SCIEX OS Software, the core engine running SCIEX innovations. Today, SCIEX OS Software becomes available on the Echo® MS System and the SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP® Ready. “SCIEX OS Software has made mass spec more accessible. […]

Enhancements for the Waters Xevo G2-XS QTof, SYNAPT XS and SELECT SERIES Cyclic IMS Instruments Accelerate Biomedical and Pharmaceutical Research   ILFORD, Mass.– Waters Corporation (NYSE:WAT) announced today a new fragmentation technique and an imaging option for its high-resolution mass spectrometers giving research scientists working across a broad range of end markets including biomedical, biopharmaceutical and […]

The appointment will support a strategic expansion into large-scale proteomics applications across the drug development value chain. (Schlieren (Zurich) Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announces today the appointment of Dr. Patrick Vink as Chairman of the Board of Directors. Dr. Vink replaces Mr. Harry Welten, who joined the Biognosys […]

iMScope QT Shimadzu is announcing the introduction of the new “iMScope QT” imaging mass microscope, to be released on 9 June 2020. This revolutionary product, boasting world-class analysis speeds and imaging capabilities, comes with an in-built optical microscope and can also be used as a liquid chromatograph mass spectrometer. It is the successor to the […]

ZURICH–(BUSINESS WIRE)– Celerion announced today the expansion of specialized high-resolution mass spectrometry (HR-MS) profiling capabilities demonstrating their commitment to further assisting sponsors in meeting the regulatory requirements to characterize and quantify drug metabolites and their potential for impacting drug effect as part of the process to becoming an approved therapeutic product. Celerion has created a […]

Joint study between Shimadzu and CHU University Hospital of Montpellier / Mass spectrometry-based blood amyloid-beta analysis / Opening the door to new advancements in research Shimadzu, one of the world leaders in analytical instrumentation, introduces the collaboration with the Clinical Laboratory and Proteomics Platform of the CHU University Hospital of Montpellier, France. With the team […]